# Dolphin Medical (NSE: DOLPHMED) share price, financials and shareholding

Source: https://app.pivotnow.in/stock/DOLPHMED · Pivot · prices to 22 Oct 2026

With a market capitalisation of ₹12 Cr, it ranks 3824th by market cap among the 4,183 NSE companies Pivot tracks (a small-cap company by SEBI's rank bands). It belongs to the Pharma & Healthcare sector; its industry is Diagnostics & Research.

Its return on equity was −0.4% in FY16.

## Key numbers

| Metric | Value |
| --- | --- |
| Market cap | ₹12 Cr |
| ROE | −0.4% (FY16) |
| ROCE | −0.2% (FY16) |
| Debt to equity | 0.64 |

## Annual results (₹ crore)

| Fiscal year | Revenue | Net profit |
| --- | --- | --- |
| FY16 | ₹1 Cr | −₹0 Cr |
| FY15 | ₹0 Cr | −₹1 Cr |
| FY14 | ₹1 Cr | −₹1 Cr |
| FY13 | ₹1 Cr | −₹2 Cr |
| FY12 | ₹4 Cr | −₹1 Cr |
| FY11 | ₹4 Cr | ₹0 Cr |

## Peers

| Company | Price | Market cap | P/E | ROE |
| --- | --- | --- | --- | --- |
| [Starsource Mult](https://app.pivotnow.in/stock/STARSOURCE) | — | ₹14 Cr | — | — |
| [Norris Medicine](https://app.pivotnow.in/stock/NORRIS) | — | ₹14 Cr | — | — |
| [ORTIN GLOBAL](https://app.pivotnow.in/stock/ORTINGLOBE) | ₹13.53 | ₹11 Cr | — | — |
| [Beryl Drugs](https://app.pivotnow.in/stock/BERLDRG) | — | ₹11 Cr | — | — |
| [Global Longlife](https://app.pivotnow.in/stock/GLHRL) | — | ₹10 Cr | — | — |
| [Looks Health](https://app.pivotnow.in/stock/LOOKS) | — | ₹10 Cr | — | — |

## Questions and answers

### What is the market cap of Dolphin Medical?

Dolphin Medical's market capitalisation is ₹12 Cr (₹12 Cr) at the 22 Oct 2026 close, ranking 3824th among the NSE companies Pivot tracks.

### What is the ROE and ROCE of Dolphin Medical?

Return on equity was −0.4% in FY16 and return on capital employed was −0.2% in FY16 (consolidated figures).

### Is Dolphin Medical a debt-free company?

No. Dolphin Medical's debt-to-equity ratio was 0.64 in FY16, with total debt of ₹8 Cr.

### Who are Dolphin Medical's competitors?

The listed Pharma & Healthcare companies closest to Dolphin Medical by market cap are Starsource Mult, Norris Medicine, ORTIN GLOBAL, Beryl Drugs, Global Longlife and Looks Health.

### Is Dolphin Medical a good stock to buy?

Pivot does not give buy or sell recommendations. This page sets out Dolphin Medical's price history, valuation, profitability, quarterly results and ownership so you can judge it yourself, and Pivot's chart lets you test a strategy on DOLPHMED against its own history before risking money. This is analysis, not financial advice.

---

Sources: NSE end-of-day bars (Pivot's market data store); Company filings via Moneycontrol; Exchange shareholding-pattern filings. This is analysis, not financial advice. Pivot is not a broker or a SEBI-registered investment adviser.